Home › Funds › Patient Square Capital LP › DBVT
Patient Square Capital LP position in DBVT
DBV Technologies SA · Health Care
Patient Square Capital LP reported holding 1,105,606 shares of DBVT (DBV Technologies SA) in its Q3 2026 13F filing — a position valued at US$13.0M, representing 2.07% of its reported portfolio and ranking #12 among its reported holdings. Patient Square Capital LP has disclosed DBVT holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Patient Square Capital LP's DBVT position evolved
Patient Square Capital LP first disclosed a stake in DBVT in Q4 2025 at 359,050 shares (US$6.9M). The position peaked in Q2 2026 at 909,474 shares, worth US$14.9M. Across 4 filings, Patient Square Capital LP increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,105,606 shares valued at US$13.0M — an increase of 196,132 shares quarter over quarter.. Notable position changes include a 93% increase in Q1 2026 (shares fell 21% over the following quarter), a 31% increase in Q2 2026 (shares fell 28% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 359.05K | $6.88M | New |
| Q1 2026 | 693.53K | $14.49M | Add |
| Q2 2026 | 909.47K | $14.92M | Add |
| Q3 2026 | 1.11M | $13.00M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About DBVT and 13F data
DBVT (DBV Technologies SA) is a Health Care company. 48 other funds we track also report a position in DBVT — the largest reported positions include MPM BioImpact LLC (US$60.1M), Siren, L.L.C. (US$27.7M), PERCEPTIVE ADVISORS LLC (US$27.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding DBVT
- MPM BioImpact LLC 3.67M sh · $60.13M · Q2 2026
- Siren, L.L.C. 2.36M sh · $27.71M · Q3 2026
- PERCEPTIVE ADVISORS LLC 1.65M sh · $27.11M · Q2 2026
- Vivo Capital, LLC 1.84M sh · $21.69M · Q3 2026
- Logos Global Management LP 915.00K sh · $15.01M · Q2 2026
- Octagon Capital Advisors LP 574.20K sh · $9.42M · Q2 2026
- Redmile Group, LLC 410.44K sh · $6.73M · Q2 2026
- Elmind Capital, LP 265.00K sh · $4.35M · Q2 2026
- Ishara Investments LP 184.50K sh · $3.03M · Q2 2026
- Yiheng Capital Management, L.P. 170.14K sh · $2.79M · Q2 2026
- GREAT POINT PARTNERS LLC 156.91K sh · $2.57M · Q2 2026
More on Patient Square Capital LP
FAQ
How long has Patient Square Capital LP held DBVT?
Patient Square Capital LP has disclosed DBVT holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Patient Square Capital LP's current position in DBVT?
As of Q3 2026, Patient Square Capital LP holds 1.11M shares of DBVT (DBV Technologies SA), valued at $13.00M, representing 2.07% of its reported portfolio and ranking #12.
Has Patient Square Capital LP been buying or selling DBVT?
In the latest 13F filing (Q3 2026), Patient Square Capital LP increased its position in DBVT. The position peaked in Q2 2026 at 909.47K shares.
Which other funds hold DBVT?
Other major institutional holders of DBVT include MPM BioImpact LLC, Siren, L.L.C., PERCEPTIVE ADVISORS LLC, among 48 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.